Sandbox Reserved 1783
From Proteopedia
(Difference between revisions)
Line 10: | Line 10: | ||
The bile salts transported by NTCP in the gastrointestinal tract are involved in digestion, nutrient absorption, fat breakdown, and lipid soluble nutrient transport. <Ref> Maldonado-Valderrama, J., Wilde, P., Macierzanka, A., & Mackie, A. (2011). The role of bile salts in digestion. Advances in colloid and interface science, 165(1), 36–46. [https://doi.org/10.1016/j.cis.2010.12.002 DOI: 10.1016/j.cis.2010.12.002]. </Ref> NTCP is found within the basolateral membrane hepatocytes. <Ref name="Asami"> Asami J, Kimura KT, Fujita-Fujiharu Y, Ishida H, Zhang Z, Nomura Y, Liu K, Uemura T, Sato Y, Ono M, Yamamoto M, Noda T, Shigematsu H, Drew D, Iwata S, Shimizu T, Nomura N, Ohto U. Structure of the bile acid transporter and HBV receptor NTCP. Nature. 2022 Jun; 606 (7916):1021-1026. [https://dx.doi.org/10.1038/s41586-022-04845-4 DOI: 10.1038/s41586-022-04845-4]. </Ref> The uptake of bile salts into the liver also allow for drugs and fat soluble vitamins to be both absorbed and excreted in the small intestine. NTCP also acts as a receptor for Hepatitis B virus (HBV) and Hepatitis D virus (HDV) which infect human livers through endocytosis when bound. The myristoylated (myr) <scene name='95/952711/Pres1_binding_area_on_ntcp/3'>pre-S1</scene> domain of HBV, specifically residues 8-17, is critical for its binding to NTCP which halts the uptake of bile salts, indicating that HBV/HDV bind to NTCP at the same site as bile salts. <ref name="Goutam"/> | The bile salts transported by NTCP in the gastrointestinal tract are involved in digestion, nutrient absorption, fat breakdown, and lipid soluble nutrient transport. <Ref> Maldonado-Valderrama, J., Wilde, P., Macierzanka, A., & Mackie, A. (2011). The role of bile salts in digestion. Advances in colloid and interface science, 165(1), 36–46. [https://doi.org/10.1016/j.cis.2010.12.002 DOI: 10.1016/j.cis.2010.12.002]. </Ref> NTCP is found within the basolateral membrane hepatocytes. <Ref name="Asami"> Asami J, Kimura KT, Fujita-Fujiharu Y, Ishida H, Zhang Z, Nomura Y, Liu K, Uemura T, Sato Y, Ono M, Yamamoto M, Noda T, Shigematsu H, Drew D, Iwata S, Shimizu T, Nomura N, Ohto U. Structure of the bile acid transporter and HBV receptor NTCP. Nature. 2022 Jun; 606 (7916):1021-1026. [https://dx.doi.org/10.1038/s41586-022-04845-4 DOI: 10.1038/s41586-022-04845-4]. </Ref> The uptake of bile salts into the liver also allow for drugs and fat soluble vitamins to be both absorbed and excreted in the small intestine. NTCP also acts as a receptor for Hepatitis B virus (HBV) and Hepatitis D virus (HDV) which infect human livers through endocytosis when bound. The myristoylated (myr) <scene name='95/952711/Pres1_binding_area_on_ntcp/3'>pre-S1</scene> domain of HBV, specifically residues 8-17, is critical for its binding to NTCP which halts the uptake of bile salts, indicating that HBV/HDV bind to NTCP at the same site as bile salts. <ref name="Goutam"/> | ||
- | [[Image:Bile Salt structure.png|300 px|left|thumb|'''Figure 2.''' Bile Salt Structure. Chemical structure of bile salt molecule. Bile salt is derivative of cholesterol, as it is a steroid.]] | + | [[Image:Bile Salt structure.png|300 px|left|thumb|'''Figure 2.''' Bile Salt Structure. Chemical structure of bile salt molecule. Bile salt is derivative of cholesterol, as it is a steroid. Bile salts are also the main components of bile.]] |
== Structural Overview == | == Structural Overview == | ||
Line 18: | Line 18: | ||
There are two significant patches in the NTCP structure that facilitate ligand binding. Residues 84-87 of NTCP are <scene name='95/952711/Binding_patch_1/1'>Patch 1</scene>, which are located on the TM2-TM3 loop in the core domain. This patch is also considered the extracellular region of the binding tunnel within NTCP. Residues 157-165 of NTCP are associated with <scene name='95/952711/Binding_site_2_with_surface/1'>Patch 2</scene>. They are located on the N-terminal half of the TM5 in the panel domain (residue sequence: KGIVISLVL). Patch 2 is also located in the extracellular region of the binding tunnel. These residues' importance was determined through mutations of these residues and examined through pull-down assays. <ref name="Asami"/> The pre-S1 domain of HBV/HDV binds to the patches on NTCP in order to transport the virus from the exterior of NTCP to the interior binding tunnel to infect human liver cells.<ref name="Goutam"/> | There are two significant patches in the NTCP structure that facilitate ligand binding. Residues 84-87 of NTCP are <scene name='95/952711/Binding_patch_1/1'>Patch 1</scene>, which are located on the TM2-TM3 loop in the core domain. This patch is also considered the extracellular region of the binding tunnel within NTCP. Residues 157-165 of NTCP are associated with <scene name='95/952711/Binding_site_2_with_surface/1'>Patch 2</scene>. They are located on the N-terminal half of the TM5 in the panel domain (residue sequence: KGIVISLVL). Patch 2 is also located in the extracellular region of the binding tunnel. These residues' importance was determined through mutations of these residues and examined through pull-down assays. <ref name="Asami"/> The pre-S1 domain of HBV/HDV binds to the patches on NTCP in order to transport the virus from the exterior of NTCP to the interior binding tunnel to infect human liver cells.<ref name="Goutam"/> | ||
- | [[Image:Figuredomain.png|450 px|right|thumb|'''Figure 3.''' Cartoon of NTCP topology.]] | + | [[Image:Figuredomain.png|450 px|right|thumb|'''Figure 3.''' Cartoon of NTCP topology. This image depicts a basic overview of NTCP structure. The panel domain is shown in blue, while the core domain is shown in pink and purple. The ICH and ECH connect their respective domains to the other. The N-terminus, as shown, is extracellular, whereas the C-terminus is intracellular.]] |
=== Binding Pocket === | === Binding Pocket === |
Revision as of 22:37, 10 April 2023
This Sandbox is Reserved from February 27 through August 31, 2023 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1765 through Sandbox Reserved 1795. |
To get started:
More help: Help:Editing |
Sodium Taurocholate Co-Transporting Peptide
|
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Goutam, K., Ielasi, F.S., Pardon, E. et al. Structural basis of sodium-dependent bile salt uptake into the liver. Nature 606, 1015–1020 (2022). DOI: 10.1038/s41586-022-04723-z.
- ↑ Maldonado-Valderrama, J., Wilde, P., Macierzanka, A., & Mackie, A. (2011). The role of bile salts in digestion. Advances in colloid and interface science, 165(1), 36–46. DOI: 10.1016/j.cis.2010.12.002.
- ↑ 3.0 3.1 Asami J, Kimura KT, Fujita-Fujiharu Y, Ishida H, Zhang Z, Nomura Y, Liu K, Uemura T, Sato Y, Ono M, Yamamoto M, Noda T, Shigematsu H, Drew D, Iwata S, Shimizu T, Nomura N, Ohto U. Structure of the bile acid transporter and HBV receptor NTCP. Nature. 2022 Jun; 606 (7916):1021-1026. DOI: 10.1038/s41586-022-04845-4.
- ↑ Xiangbing Qi, Wenhui Li. (2022). Unlocking the secrets to human NTCP structure. The Innovation, Vol. 3, Issue 5. 100294, ISSN 2666-6758, DOI: 10.1016/j.xinn.2022.100294.
- ↑ Liu, H., Irobalieva, R.N., Bang-Sørensen, R. et al. Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver. Cell Res 32, 773–776 (2022). DOI: 10.1038/s41422-022-00680-4.
- ↑ Vlahcevic, Z., Buhac, I., et al. Bile Acid Metabolism in Patients with Cirrhosis. Gastroenterology vol. 60, 491-498 (1971). DOI: 10.1016/S0016-5085(71)80053-7.